Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
| Country | European Union (all member states) |
|---|---|
| Deadline | 2027-09-16 (298 days left) |
| Published | 2027-02-10 |
| Sectors | Health & life sciences, Research & innovation, SME & startup support |
| Source | EU Funding & Tenders portal |
Summary
Expected Outcome: Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes: Patients with rare or very rare cancers or canc…
The buyer, the value, the full description and the link to the official notice are available with a free account.